Redding, California - August 13, 2024
Biopharmaceutical Processing Equipment and Consumables Market to be Worth $75.72 Billion by 2031
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031
Meticulous Research®– a leading global market research company, published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031.”
According to this latest publication from Meticulous Research, The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031. Global demand for biopharmaceutical production is driving a number of pharmaceutical and biopharmaceutical businesses, as well as contract manufacturing organizations (CMOs), to increase the production of these drugs. The demand for the consumables and equipment needed for biopharmaceutical processing is predicted to rise in the upcoming years as a result of the expansion of their current manufacturing capacities to meet the surge in demand. Further factors that are anticipated to fuel demand for processing equipment for commercial bioproduction applications are the increasing incidence of different infectious and chronic diseases as well as regulatory changes that support the use of biosimilars.
Key Players
The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook
The global biopharmaceutical processing equipment and consumables market is segmented by Product Type (Filtration Systems, Chromatography Equipment and Consumables {Chromatography Consumables & Chromatography Equipment}, Bioreactors {Reusable Bioreactors, Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), & Academic and Research Institutes), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.
The global biopharmaceutical processing equipment and consumables market is segmented by product type into filtration systems, chromatography equipment and consumables, bioreactors, cell culture products, mixers/mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, and other consumables and accessories. The filtration systems segment is projected to hold the largest share of 22.3% in the global biopharmaceutical processing equipment and consumables market, in 2024. This dominant share is due to the frequent use of filtration at various stages of bioprocessing, advancements in filtration technologies, and the growing preference for single-use filtration systems.
The global biopharmaceutical processing equipment and consumables market is segmented by application into commercial bioproduction and research bioproduction. In 2024, the commercial bioproduction segment is expected to capture the largest share, estimated at 77.5%. This substantial share is driven by the increasing number of biopharmaceuticals advancing through clinical development and the imminent patent expirations of biologics. Additionally, the significant demand for monoclonal antibodies used in treating chronic conditions such as cancer, autoimmune diseases, and diabetes further bolsters this segment’s dominance.
The global biopharmaceutical processing equipment and consumables market is divided by end user into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. In 2024, pharmaceutical and biopharmaceutical companies are projected to hold the largest market share. This is due to the rising demand for biopharmaceutical equipment driven by commercial bioproduction needs, increased research initiatives leading to new biologics and biosimilars, and the high volume of biopharmaceutical production worldwide.
Geographic Review
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa. In 2024, Europe is projected to hold the largest share of 33.5% in the biopharmaceutical processing equipment and consumables market. Within Europe, Germany is expected to hold the largest market share. This prominent position is attributed to Germany's significant pharmaceutical export volumes, substantial government grants and funding for biotech and biopharmaceutical companies, and the expansion of biopharmaceutical companies’ capacities to produce biologics-based drugs and therapeutics in response to growing market demand.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Key questions answered in the report-
- Which are the high-growth market segments in terms of product type, application, end user, and regions/countries?
- What was the historical market for biopharmaceutical processing equipment and consumables across the globe?
- What are the market forecasts and estimates for the period 2024–2031?
- What are the major drivers, restraints, challenges, opportunities, and trends in the global market of biopharmaceutical processing equipment and consumables?
- Who are the major players in the global biopharmaceutical processing equipment and consumables market?
- How is the competitive landscape, and who are the market leaders in the global biopharmaceutical processing equipment and consumables market?
- What are the recent developments in the biopharmaceutical processing equipment and consumables market?
- What are the different strategies adopted by the major players in the biopharmaceutical processing equipment and consumables market?
- What are the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
